- Report
- May 2026
- 153 Pages
Global
From €3592EUR$3,950USD£3,078GBP
- Report
- August 2025
- 70 Pages
India
From €3183EUR$3,500USD£2,727GBP
- Report
- December 2024
- 85 Pages
Spain
From €3183EUR$3,500USD£2,727GBP
- Report
- November 2023
- 77 Pages
France
From €3183EUR$3,500USD£2,727GBP
- Report
- October 2023
- 138 Pages
North America
From €3638EUR$4,000USD£3,117GBP
- Report
- September 2022
- 116 Pages
Global
From €3592EUR$3,950USD£3,078GBP
- Report
- June 2025
- 400 Pages
Global
From €4501EUR$4,949USD£3,856GBP
- Report
- November 2024
- 96 Pages
Global
From €3500EUR$4,123USD£3,104GBP
- Book
- July 2025
North America
Oral cancer is a type of cancer that affects the mouth, lips, and throat. It is a subset of head and neck cancer, which is a type of oncology. Symptoms of oral cancer include sores in the mouth that do not heal, lumps in the neck, and difficulty swallowing. Treatment for oral cancer typically involves surgery, radiation, and chemotherapy.
The oral cancer market is a subset of the larger oncology market. It is a rapidly growing market, driven by increasing prevalence of the disease, technological advancements, and increasing awareness of the disease. The market is expected to grow due to the increasing demand for early diagnosis and treatment.
Some companies in the oral cancer market include AstraZeneca, Bristol-Myers Squibb, Merck, Pfizer, and Roche. Show Less Read more